Bren Bio Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 28-12-2024
- Paid Up Capital ₹ 2.50 M
as on 28-12-2024
- Company Age 3 Year, 7 Months
- Last Filing with ROC 31 Mar 2022
About Bren Bio Life Sciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 2.50 M, as per Ministry of Corporate Affairs (MCA) records.
Jayarama Reddy, Arjun Reddy, and Deepa Reddy serve as directors at the Company.
- CIN/LLPIN
U24100KA2021PTC148065
- Company No.
148065
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Jun 2021
- Date of AGM
09 Dec 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Bren Bio Life Sciences?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jayarama Reddy  | Director | 02-Jun-2021 | Current |
| Arjun Reddy | Director | 02-Jun-2021 | Current |
| Deepa Reddy | Director | 02-Jun-2021 | Current |
Financial Performance of Bren Bio Life Sciences.
Enhance accessibility to Bren Bio Life Sciences's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Bren Bio Life Sciences?
Unlock access to Bren Bio Life Sciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Bren Corporation Private LimitedActive 12 years 7 monthsJayarama Reddy, Arjun Reddy and 1 more are mutual person
- Home Studio (India) Private LimitedActive 20 years 1 month
Jayarama Reddy and Deepa Reddy are mutual person
- Bren Sports City Private LimitedActive 4 years 6 months
Jayarama Reddy, Arjun Reddy and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Bren Bio Life Sciences?
Bren Bio Life Sciences has a workforce of 0 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bren Bio Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bren Bio Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
